UBS AM
SWAV

UBS AM’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

UBS AM’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64,773
Closed -$21.1M – 2899
2024
Q1 		$21.1M Hold
64,773
– – 0.01% 774
2023
Q4 		$12.3M Buy
64,773
+7,096
+12% +$1.34M ﹤0.01% 919
2023
Q3 		$11.5M Buy
57,677
+15,561
+37% +$3.68M 0.01% 914
2023
Q2 		$9.13M Hold
42,116
– – ﹤0.01% 1008
2023
Q1 		$9.13M Buy
42,116
+1,523
+4% +$297K ﹤0.01% 1008
2022
Q4 		$8.35M Buy
40,593
+1,966
+5% +$497K ﹤0.01% 1007
2022
Q3 		$10.7M Sell
38,627
-7,987
-17% -$2.03M 0.01% 932
2022
Q2 		$8.91M Buy
46,614
+4,539
+11% +$801K ﹤0.01% 996
2022
Q1 		$8.72M Buy
42,075
+5,159
+14% +$851K ﹤0.01% 1121
2021
Q4 		$6.58M Buy
36,916
+1,309
+4% +$258K ﹤0.01% 1292
2021
Q3 		$7.33M Buy
35,607
+543
+2% +$107K ﹤0.01% 1211
2021
Q2 		$6.65M Buy
35,064
+5,161
+17% +$845K ﹤0.01% 1252
2021
Q1 		$3.9M Sell
29,903
-1,110
-4% -$133K ﹤0.01% 1453
2020
Q4 		$3.22M Buy
31,013
+7,444
+32% +$645K ﹤0.01% 1490
2020
Q3 		$1.79M Hold
23,569
– – ﹤0.01% 1598
2020
Q2 		$1.12M Buy
23,569
+15,069
+177% +$621K ﹤0.01% 1745
2020
Q1 		$282K Buy
+8,500
New +$338K ﹤0.01% 2174

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS AM's SWAV Position: Q2 2024 in Review

UBS AM sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 64,773 shares — an estimated $21.1M sold.

UBS AM first reported a position in SWAV in Q1 2020 and held it in 17 quarters. The position peaked at $21.1M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • UBS AM reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • UBS AM sold 64,773 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $21.1M.
  • UBS AM first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2020 and held it in 17 quarters.
  • UBS AM's Shockwave Medical, Inc. Common Stock position peaked at $21.1M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.